We read with great interest the study by Lobo and colleagues [1] in a recent issue of Critical Care. Th e authors stated that fl uid restriction during optimization of oxygen delivery (DO 2 ) using dobutamine improves patient outcome after major surgery. Previous studies have shown that hemodynamic optimization using either an individualized goal-directed fl uid substitution or an inotrope to maximize DO 2 reduces postoperative morbidity and hospital length of stay [2] . Although the study by Lobo and colleagues sheds new light on the use of an inotrope during major surgery, we believe that the approach they support raises some unanswered questions.
We read with great interest the study by Lobo and colleagues [1] in a recent issue of Critical Care. Th e authors stated that fl uid restriction during optimization of oxygen delivery (DO 2 ) using dobutamine improves patient outcome after major surgery. Previous studies have shown that hemodynamic optimization using either an individualized goal-directed fl uid substitution or an inotrope to maximize DO 2 reduces postoperative morbidity and hospital length of stay [2] . Although the study by Lobo and colleagues sheds new light on the use of an inotrope during major surgery, we believe that the approach they support raises some unanswered questions.
Our main concern is about using a specifi c target value for DO 2 -that is, an oxygen delivery index (DO 2 i) of greater than 600 mL/minute per m 2 . It must be emphasized that the treatment goal for DO 2 i was achieved in only a tiny proportion of patients while using high-dose infusions. Also, it may be somewhat confusing for readers to support the benefi t of maximizing DO 2 while a better outcome was obtained despite slightly lower levels of DO 2 i (though the levels were not signifi cantly lower). One can therefore question the rationale of 'maximi zation' rather than use an individualized approach of tissue O 2 needs.
Adequacy of tissue oxygenation is defi ned by a DO 2 adapted to O 2 demand [3] . However, the optimal value of DO 2 to meet O 2 needs is unknown because of its relationship to metabolic demand and individual variations of the critical DO 2 [2] . Th erefore, we believe that it is better to address the need for inotrope infusion given the VO 2 -to-DO 2 (oxygen consumption-to-oxygen delivery) relationship (that is, the O 2 extraction) or the VCO 2 -to-DO 2 (carbon dioxide production-to-oxygen delivery) relation ship (or both) [4] rather than to target any specifi c value for DO 2 [3] . Such an approach would help reduce the amount of fl uid infused while allowing an individualized inotrope infusion [5] .
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We thank Futier and Vallet for addressing some issues in our study. We certainly agree that the goal of 600 mL/ minute per m 2 is, to a certain extent, trouble some and that an individualized hemodynami c approach would be more coherent. However, given the fi ndings of two systematic reviews on the use of pre-emptive hemodynamic intervention in high-risk surgical patients [6, 7] , we accept that DO 2 , instead of the VO 2 -to-DO 2 relationship, should be the goal of therapy. Th e review by Hamilton and colleagues [6] included 29 studies involving 4,805 patients. Th e authors showed signifi cant reductions in mortality by using cardiac index or DO 2 as endpoints and not for other goals. Gurgel and do Nascimento [7] reported that therapies directed at increasing central venous oxygen saturation (ScvO 2 ) or mixed venous oxygen saturation (SvO 2 ) did not signifi cantly reduce mortality. During surgery, many factors infl uence VO 2 and not all are indicative of hypoperfusion [8] . Anesthesia determines a marked decrease in VO 2 and carbon dioxide production refl ecting reduction in whole-body metabolism.
Th e critical DO 2 is the point below which the dependence between DO 2 and VO 2 is observed and this point varies for diff erent organs [9] . Regional hypoperfusion may occur despite normal global oxygen extraction rate. In our view, it is not the achievement of the '600' value that determines better o utcomes. Rather, what might count is keeping DO 2 above baseline while trying to reach this number and, as a consequence, prevent oxygen debt. By targeting a supranormal value, we actually increase the likelihood of having more patients without oxygen debt and for longer periods. In addition, doses of inotropes were not so high and there were no adverse events related to their use. Many changes will come with new knowledge, and still it seems to us that Shoemaker and colleagues [10] , who more than 20 years ago reported the close correlation between DO 2 and the development of multiple organ failure and death, are right.
